AUSTIN, Texas, Dec. 10, 2010 /PRNewswire-FirstCall/ — Hanger
Orthopedic Group, Inc. (NYSE:
HGR) announced today the pricing of the previously announced
public offering of 2,000,000 shares of its common stock by Ares
Corporate Opportunities Fund, L.P. at a public offering price of
$20.00 per share. The transaction is expected to close on
December 15, 2010. The shares sold were a portion of the
currently outstanding shares issued to Ares in August 2008 in
connection with the conversion of all of Hanger’s Series A
Convertible Preferred Stock into common stock. Upon completion of
the public offering of these shares, the overall number of
outstanding shares of Hanger Orthopedic Group, Inc. will be
unchanged. Hanger Orthopedic Group, Inc. will not receive any
proceeds from this transaction. Barclays Capital Inc. is the sole
underwriter for the offering. The offering is being made only by
means of a written prospectus forming part of the effective
registration statement. Copies of the preliminary and final
prospectus related to this offering may be obtained from Barclays
Capital, c/o Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, (888) 603-5847 or email
barclaysprospectus@broadridge.com
The shares are being sold pursuant to an effective registration
statement that was previously filed with the Securities and
Exchange Commission. This announcement does not constitute an offer
to sell or the solicitation of an offer to buy these securities,
nor shall there be any sale of these securities in any jurisdiction
in which the offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of that
jurisdiction.
About Hanger Orthopedic Group, Inc.
Hanger Orthopedic Group, Inc., headquartered in Austin, Texas,
is the world’s
‘/>”/>
